Form 4: Abeona Therapeutics Director Mark Alvino Acquires Shares as Part of Annual Grant

Director Mark Alvino acquired 11,797 shares of Abeona Therapeutics common stock as part of the 2024 annual grant to the board of directors.

Summary

• On August 26, 2024, Mark Alvino, a director of Abeona Therapeutics Inc., acquired 11,797 shares of common stock.
• The acquisition was part of the 2024 annual grant to the board of directors.
• These shares were withheld until all employees/management were allocated their shares and to enable onboarding of two new Board members.
• The price per share was $0.
• Following the transaction, Alvino directly owns 72,334 shares of Abeona Therapeutics.
• The restricted stock will vest on August 26, 2025.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a routine transaction (stock grant) and insider ownership, which can be seen as a sign of confidence. There are no explicitly negative elements.

Positives

• The acquisition of shares by a director demonstrates confidence in the company.

Future Outlook

The restricted stock will vest on August 26, 2025.

Industry Context

This filing is a routine disclosure of stock ownership changes by a company insider, which is common in publicly traded companies. It provides transparency to investors regarding the holdings of key personnel.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider ownership.
• The vesting of the stock grant incentivizes the director to contribute to the company's long-term success.

Key Dates